Abstract
Background
Nonalcoholic steatohepatitis (NASH) associated with obesity is one of the leading causes of liver failure requiring transplant, yet guidelines for the management of obesity in these scenarios are not always followed. In order to decrease incidence of NASH in the new liver, we studied the feasibility of simultaneous liver transplant and bariatric surgery.
Materials and Methods
We retrospectively identified patients who underwent simultaneous liver transplant and sleeve gastrectomy at our hospital site between November 24, 2019, and April 14, 2022. Demographics, surgical data, postoperative adverse events, and weight loss data were collected.
Results
Ten patients met inclusion criteria. Mean body mass index (BMI) at the time of transplant was 43.1 ± 5.3 kg/m2, and mean length of hospital stay was 10.8 ± 5.22 days. Within 30 days after surgery, 7 patients reported adverse effects, and 2 were readmitted. Mean BMI at 6-month follow-up was 30.6 ± 2.5 kg/m2. Mean percentage excess weight (in pounds) loss was 48.1 ± 11.4%, 58.6 ± 8.9%, and 66.1 ± 15.3% at 3-, 6-, and 12-month follow-up, respectively. Three patients had an increase in weight at 12-month follow-up when compared to 6-month follow-up. Most patients required fewer comorbidity-related medications, and none reported adverse effects related to sleeve gastrectomy.
Conclusions
Bariatric surgery at the time of liver transplant is safe and has minimal adverse effects. Results include substantial postoperative weight loss, improvement in comorbidities, and decreased risk of NASH in the new liver. Further studies with larger cohorts are required to confirm the findings of this study.
Graphical abstract
Similar content being viewed by others
Abbreviations
- %EWL:
-
Percentage excess weight loss
- BMI:
-
Body mass index
- NASH:
-
Nonalcoholic steatohepatitis
References
Wang Y, Beydoun MA, Liang L, et al. Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obes (Silver Spring). 2008;16(10):2323–30.
Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatol. 2016;64(1):73–84.
Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263–73.
Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterol. 2011;141(4):1249–53.
Schlansky B, Naugler WE, Orloff SL, Enestvedt CK. Higher mortality and survival benefit in obese patients awaiting liver transplantation. Transplant. 2016;100(12):2648–55.
Lin MY, Tavakol MM, Sarin A, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc. 2013;27(1):81–5.
Laish I, Braun M, Mor E, et al. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl. 2011;17(1):15–22.
Weiner R. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Dig Dis (Basel, Switzerland). 2010;28:274–9.
Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ : Bri Med J. 2013;347:f5934.
Clinical guidelines on the identification. evaluation, and treatment of overweight and obesity in adults—the evidence report. Natl Ins Health Obes Res. 1998;6(Suppl 2):51s–209s.
Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9(10):897–901.
Carson K, Washington MK, Treem WR, et al. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient. Liver Transpl Surg. 1997;3(2):174–6.
Heimbach JK, Watt KD, Poterucha JJ, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant. 2013;13(2):363–8.
Zamora-Valdes D, Watt KD, Kellogg TA, et al. Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy. Hepatol. 2018;68(2):485–95.
Cheng YL, Elli EF. Outcomes of bariatric surgery after solid organ transplantation. Obes Surg. 2020;30(12):4899–904.
Wölnerhanssen B, Peterli R. State of the art: sleeve gastrectomy. Dig Surg. 2014;31(1):40–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conclusion
Simultaneous liver transplant and sleeve gastrectomy are feasible, safe, and do not add risks or adverse events to regular liver transplantation surgery. This combined procedure also effectively reduces body weight and controls obesity-associated comorbidities. More studies with larger cohorts are needed to evaluate long-term outcomes of combined surgery so that future programs providing simultaneous bariatric surgery to obese patients undergoing liver transplant can be developed.
Ethical Approval
For this type of study, formal consent is not required.
Informed Consent
Informed consent does not apply.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
Obesity is both a major cause and a common adverse effect of liver transplant.
Simultaneous liver transplant and sleeve gastrectomy are feasible and safe.
It also effectively reduces body weight and obesity-associated comorbidities.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gunturu, N.S., Castillo-Larios, R., Bowers, S. et al. Combined Sleeve Gastrectomy with Liver Transplant in Patients with Obesity: a Feasibility Study. OBES SURG 32, 3600–3604 (2022). https://doi.org/10.1007/s11695-022-06289-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-022-06289-1